AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 279: H520-H527, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, G.
Right arrow Articles by Hintze, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, G.
Right arrow Articles by Hintze, T. H.
Vol. 279, Issue 2, H520-H527, August 2000

Depressed modulation of oxygen consumption by endogenous nitric oxide in cardiac muscle from diabetic dogs

Gong Zhao, Xiaoping Zhang, Xiaobin Xu, Michael S. Wolin, and Thomas H. Hintze

Department of Physiology, New York Medical College, Valhalla, New York 10595

Our previous study indicated that nitric oxide (NO)-dependent coronary vasodilation was impaired in conscious dogs with diabetes. Our goal was to determine whether modulation of O2 consumption by NO is depressed in canine cardiac muscle after diabetes. Diabetes was induced by injection of alloxan (40-60 mg/kg iv), dogs were killed after diabetes was induced (4-5 wk), and the cardiac muscle from the left ventricle was cut into 15- to 30-mg slices. O2 uptake by the muscle slices was measured polarographically with a Clark-type O2 electrode. S-nitroso-N-acetylpenicillamine decreased O2 consumption in normal and diabetic tissues (10-4 M, 61 ± 7 vs. 61 ± 8%, P > 0.05). Bradykinin (10-4 M)- or carbachol (CCh, 10-4 M)-induced inhibition of O2 consumption was impaired in diabetic tissues (51 ± 6 vs. 17 ± 4% or 48 ± 4 vs. 19 ± 3%, respectively, both P < 0.05 compared with normal). The inhibition of O2 consumption by kininogen or kallikrein was depressed in diabetic tissues as well. In coronary microvessels from diabetic dogs, bradykinin or ACh (10-5 M) caused smaller increases in NO production than those from normal dogs. Our results indicate that the modulation of O2 consumption by endogenous, but not exogenous, NO is depressed in cardiac muscle from diabetic dogs, most likely because of decreased release of NO from the vascular endothelium.

diabetes; kinin


This article has been cited by other articles:


Home page
 DiabetesHome page
M. M. Madsen, H. M. Sondergaard, M. Bottcher, N. H. Buus, O. Schmitz, H. E. Botker, and T. T. Nielsen
Impact of Type 2 Diabetes on Nitric Oxide and Adrenergic Modulation of Myocardial Perfusion
Diabetes, February 1, 2007; 56(2): 468 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Koller and Z. Bagi
Nitric oxide and H2O2 contribute to reactive dilation of isolated coronary arterioles
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2461 - H2467.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Li, T. Jue, J. Edwards, X. Wang, and T. H. Hintze
Changes in NO bioavailabilty regulate cardiac O2 consumption: control by intramitochondrial SOD2 and intracellular myoglobin
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H47 - H54.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R.P. Mason, P. Marche, and T.H. Hintze
Novel Vascular Biology of Third-Generation L-Type Calcium Channel Antagonists: Ancillary Actions of Amlodipine
Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2155 - 2163.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Bagi, A. Koller, and G. Kaley
Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1404 - H1410.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Z. Kojic, U. Flogel, J. Schrader, and U. K. M. Decking
Endothelial NO formation does not control myocardial O2 consumption in mouse heart
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H392 - H397.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Peralta, P. V. Finocchietto, D. Converso, F. Schopfer, M. C. Carreras, and J. J. Poderoso
Modulation of mitochondrial nitric oxide synthase and energy expenditure in rats during cold acclimation
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2375 - H2383.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Z. He, C. Rask-Madsen, and G.L. King
Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. V. Brodsky, S. Gao, H. Li, and M. S. Goligorsky
Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2130 - H2139.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online